All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Scorr-Insert

X

Find Drugs for Trauma (Emergency, Injury, Surgery) in Phase II Clinical Development in FRANCE

A collaboration with SCORR Marketing

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Inotrem S.A

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

FRANCE France

Post An Enquiry

ASCO 2020

Participation Not Confirmed

Update your events

Inotrem Secures Strategic Licensing Agreement for a Companion Diagnostics Test in Septic Shock

Contact the Supplier

Lead Product(s): Nangibotide

Therapeutic Area: Trauma (Emergency, Injury, Surgery)

Highest Development Status: Phase II Product Type: Large molecule

Partner/Sponsor/Collaborator: Roche Diagnostics GmbH

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement January 21, 2020

Details:

Inotrem entered a worldwide licensing agreement with Roche Diagnostics for the commercialization of a mechanism-based companion diagnostic test using a soluble plasma protein.